PRESENILIN DOMAINS AND RECONSTITUTION OF CATALYSIS
PRESENILIN DOMAINS AND RECONSTITUTION OF CATALYSIS
批准号:
7269823
负责人:
SAMUEL E. GANDY
金额:
$32.95万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2010-06-30
关键词:
AddressAmyloid beta-ProteinAmyloid beta-Protein PrecursorAntibodiesAspartic EndopeptidasesBaculovirusesBrainC-terminalCatalysisCell LineCellsCleaved cellComplexConditionCultured CellsDataDrug FormulationsEnsureEnvironmentEnzymesGenerationsGoalsHandHumanIncubatedInsectaIntegral Membrane ProteinInvestigationLactobacillusLeftLocalizedMediatingMembraneMolecular WeightMusMutagenesisMutateN-terminalOccupationsOutcomePeptidesPhenotypePhosphorylationPhysiological ProcessesPoint MutationProcessProtease InhibitorProtein FragmentProtein OverexpressionProteinsProteolysisPublicationsPublished CommentRecombinantsRelative (related person)ReportingResearchResearch PersonnelSecond Messenger SystemsStaining methodStainsStandards of Weights and MeasuresStructureSystemTimeTransgenesTransgenic MiceTransgenic OrganismsUncertaintyamyloid precursor protein processingchapsoconceptdesigngamma secretasehuman APH-1 proteinhuman PEN-2 proteinin vivoinnovationmutantnicastrin proteinpresenilinprogramsreconstitutionresearch studyresponsesecond messengersecretasetrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): gamma-Secretase is the proteolytic activity that catalyzes the final step in the generation of the amyloid beta-peptide (AP) from the transmembrane Alzheimer amyloid precursor protein (APP). Growing evidence suggests that the presenilin proteins (PS1 and PS2) are required in order for gamma-secretase cleavage to occur. The PS proteins are endoproteolytically cleaved, generating an N-terminal fragment (NTF) and a C-terminal fragment (CTF). The NTF and CTF remain stably associated as heterodimers and assemble together with the partner proteins known as nicastrin, aph-1, and pen-2 proteins in order to form the high molecular weight (approximately 10/6 kDa) complex that is believed to constitute the functional gamma secretase. Gamma-Secretase cleavage is unusual in that it apparently occurs within the anhydrous environment of the membrane bilayer. The realization that numerous transmembrane proteins are processed in a similar fashion has inspired the formulation of a general concept: regulated intramembrane proteolysis, or RIP. The general goal of this proposal is to advance our understanding of the structure and function of PS proteins. In Aim 1 mutant PS molecules will be designed that permit the localization of domains that are important for (i) endoproteolytic processing of PS, and for (ii) intramembranous processing of APP to liberate Abeta40, Abeta42, and the APP intracellular domain (AICD). Successive truncation and point mutagenesis strategies will be utilized. In Aim 2, we will elucidate the conditions required for generating aspartyl proteinase activity from recombinant PS1 and its partners nicastrin, aph-1 and pen-2, following their expression in insect cells. This investigation will permit the identification of the minimal functional unit for gamma-secretase activity and potentially support the notion that PS1 is indeed the catalytic component of the gamma-secretase complex.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
-
批准号:10378457
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:SAMUEL E. GANDY
-
依托单位:
Proneurogenic Treatment for Amyloid or Tau-Based Neurodegeneration
-
批准号:9911993
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:SAMUEL E. GANDY
-
依托单位:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
-
批准号:9220567
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SAMUEL E. GANDY
-
依托单位:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
-
批准号:8596270
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SAMUEL E. GANDY
-
依托单位:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
-
批准号:9026594
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SAMUEL E. GANDY
-
依托单位:
Rehab Therapy Adjunct with a Neurogenic, Mnemoactive, A-Beta-Lowering Compound
-
批准号:8825927
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:SAMUEL E. GANDY
-
依托单位:
Model for SorCS1-mediated Diabetes with Dementia
-
批准号:8599496
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2012
-
负责人:SAMUEL E. GANDY
-
依托单位:
Generation and Characterization of Alzheimer Brain Cells
-
批准号:8370239
-
项目类别:
-
资助金额:$51.58万
-
财政年份:2012
-
负责人:SAMUEL E. GANDY
-
依托单位:
Model for SorCS1-mediated Diabetes with Dementia
-
批准号:8788636
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2012
-
负责人:SAMUEL E. GANDY
-
依托单位:
Model for SorCS1-mediated Diabetes with Dementia
-
批准号:8411973
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2012
-
负责人:SAMUEL E. GANDY
-
依托单位:
Model for SorCS1-mediated Diabetes with Dementia
-
批准号:8295466
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2012
-
负责人:SAMUEL E. GANDY
-
依托单位:
Phase 11-Grape Seed Extract as Anti-Oligomerization Agent in Alzheimer's Disease
-
批准号:8144436
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2010
-
负责人:SAMUEL E. GANDY
-
依托单位:
Phase 11-Grape Seed Extract as Anti-Oligomerization Agent in Alzheimer's Disease
-
批准号:8532827
-
项目类别:
-
资助金额:$16.44万
-
财政年份:2010
-
负责人:SAMUEL E. GANDY
-
依托单位:
Phase 11-Grape Seed Extract as Anti-Oligomerization Agent in Alzheimer's Disease
-
批准号:8008972
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2010
-
负责人:SAMUEL E. GANDY
-
依托单位:
Alzheimer Mouse Model for Intraneuronal Amyloid-Beta Oligomer Biology
-
批准号:7795314
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:SAMUEL E. GANDY
-
依托单位:
Alzheimer Mouse Model for Intraneuronal Amyloid-Beta Oligomer Biology
-
批准号:7907854
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:SAMUEL E. GANDY
-
依托单位:
Alzheimer Mouse Model for Intraneuronal Amyloid-Beta Oligomer Biology
-
批准号:8195552
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:SAMUEL E. GANDY
-
依托单位:
PRESENILIN DOMAINS AND RECONSTITUTION OF CATALYSIS
-
批准号:7117394
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2005
-
负责人:SAMUEL E. GANDY
-
依托单位:
PRESENILIN DOMAINS AND RECONSTITUTION OF CATALYSIS
-
批准号:6983927
-
项目类别:
-
资助金额:$29.41万
-
财政年份:2005
-
负责人:SAMUEL E. GANDY
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7056884
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2005
-
负责人:SAMUEL E. GANDY
-
依托单位:
海外基金